Benefits of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide, versus insulin glargine and lixisenatide monocomponents in type 2 diabetes inadequately controlled on oral agents: The LixiLan-O randomized trial
Cardiometabolic Markers: Both drugs dramatically improve key indicators
[5] [16] This multi-receptor activity drives significant reductions in appetite, caloric intake, and body weight effects that, while therapeutically promising, can also influence how the body regulates temperature
It also acts as a vital cofactor for the antioxidant enzyme glutathione peroxidase (GPx) 20
If you notice increased fatigue, hair loss, or a plateau in weight loss despite calorie deficit, you may need more protein
Evidence suggests that GLP-1s are not only effective in preventing the accumulation of amyloid beta, a protein commonly associated with Alzheimer's, but also in mitigating the hyperphosphorylation and aggregation of tau, another critical protein in the disease's progression